Related Experiment Videos

Immunocytochemical study of malignant lymphoma in serous effusions

G C Santos1, A Longatto-Filho, L V de Carvalho

  • 1Department of Pathology, Medicine School, Federal University of São Paulo State, Brazil.

Acta Cytologica
|August 10, 2000
PubMed

Insights

Cytology effectively evaluates serous effusions in malignant lymphoma (ML). Immunophenotyping lymphoid cells aids in confirming cytologic diagnoses, showing high accuracy with no false positives in this study.

Area of Science:

  • Cytopathology
  • Hematopathology
  • Immunohistochemistry

Background:

  • Serous effusions are commonly associated with malignant lymphoma (ML).
  • Accurate cytological evaluation and subclassification of ML in effusions are crucial for patient management.
  • Immunophenotyping aids in differentiating lymphoid cell types.

Purpose of the Study:

  • To cytologically evaluate serous effusions linked to ML.
  • To determine immunoreaction patterns of lymphoid cells in effusions.
  • To correlate cytomorphology with tissue diagnoses.

Main Methods:

  • Retrospective review of 4,297 serous effusions (256 with ML) from 1966-1990.
  • Immunocytochemical staining of Papanicolaou-stained cytocentrifuge slides using L-26 (pan-B) and UCHL-1 (pan-T) markers.
  • Immunohistochemical staining of tissue sections for comparison.

Main Results:

  • Cytology showed no false positive diagnoses for ML.
  • Immunocytochemistry identified pan-B positivity in 22/54 cases and pan-T in 10/54.
  • Immunohistochemistry confirmed lymphoid markers in tissue, with good correlation to cytology in most cases, though some discrepancies were noted.

Conclusions:

  • Cytology is a reliable method for diagnosing ML in serous effusions.
  • Immunophenotyping of lymphoid cells in effusions is valuable for confirming and classifying ML diagnoses.
  • High concordance between cytological and tissue-based immunophenotyping supports diagnostic accuracy.
Abstract

Related Concept Videos